Foreign Generic Drug Use Is Key To Rx Price Equity, FDA’s McClellan Says

Foreign countries could redirect billions of dollars into medical innovation by encouraging generic drug use, FDA Commissioner McClellan suggested in a speech to the Drug Information Association in Ottawa, Canada Nov. 18